Trial Profile
Local, Multicentre, Observational, Non-Interventional Prospective Study of Alogliptin Benzoate in Patients With Diabetes Mellitus Type 2
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 11 Jul 2019
Price :
$35
*
At a glance
- Drugs Alogliptin (Primary)
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- Sponsors Takeda
- 20 Jun 2018 Status changed from active, no longer recruiting to completed.
- 12 Apr 2018 Planned End Date changed from 1 Apr 2018 to 30 Apr 2018.
- 12 Apr 2018 Planned primary completion date changed from 1 Apr 2018 to 30 Apr 2018.